Borleffs JC - Search Results

1

Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection.

Geretti AM, Van Baalen CA, Borleffs JC, Van Els CA, Osterhaus AD. Geretti AM, et al. Among authors: borleffs jc. Scand J Immunol. 1994 Apr;39(4):355-62. doi: 10.1111/j.1365-3083.1994.tb03386.x. Scand J Immunol. 1994. PMID: 7908456 Free article.

2

Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.

Geretti AM, Dings ME, van Els CA, van Baalen CA, Wijnholds FJ, Borleffs JC, Osterhaus AD. Geretti AM, et al. Among authors: borleffs jc. J Infect Dis. 1996 Jul;174(1):34-45. doi: 10.1093/infdis/174.1.34. J Infect Dis. 1996. PMID: 8656011

3

In vitro and in vivo measurement of cell-mediated immunity in patients with HIV-1 infection.

Borleffs JC, Schuurman HJ, Vrehen HM, Van Schaik M, Bast EJ. Borleffs JC, et al. Scand J Immunol. 1993 Jun;37(6):634-6. doi: 10.1111/j.1365-3083.1993.tb01675.x. Scand J Immunol. 1993. PMID: 8100361

4

Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.

Vrisekoop N, van Gent R, de Boer AB, Otto SA, Borleffs JC, Steingrover R, Prins JM, Kuijpers TW, Wolfs TF, Geelen SP, Vulto I, Lansdorp P, Tesselaar K, Borghans JA, Miedema F. Vrisekoop N, et al. Among authors: borleffs jc. J Immunol. 2008 Jul 15;181(2):1573-81. doi: 10.4049/jimmunol.181.2.1573. J Immunol. 2008. PMID: 18606713

5

The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.

Cohen Stuart JW, Hazebergh MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ. Cohen Stuart JW, et al. Among authors: borleffs jc. J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):203-11. doi: 10.1097/00126334-200011010-00001. J Acquir Immune Defic Syndr. 2000. PMID: 11115950

6

Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.

Orendi JM, Bloem AC, Borleffs JC, Wijnholds FJ, de Vos NM, Nottet HS, Visser MR, Snippe H, Verhoef J, Boucher CA. Orendi JM, et al. Among authors: borleffs jc. J Infect Dis. 1998 Nov;178(5):1279-87. doi: 10.1086/314451. J Infect Dis. 1998. PMID: 9780247

7

Deficient antipneumococcal polysaccharide responses in HIV-seropositive patients.

Loeliger AE, Rijkers GT, Aerts P, Been-Tiktak A, Hoepelman AI, van Dijk H, Borleffs JC. Loeliger AE, et al. Among authors: borleffs jc. FEMS Immunol Med Microbiol. 1995 Sep;12(1):33-41. doi: 10.1111/j.1574-695X.1995.tb00171.x. FEMS Immunol Med Microbiol. 1995. PMID: 8580899

8

Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count).

Hoepelman AI, van Buren M, van den Broek J, Borleffs JC. Hoepelman AI, et al. Among authors: borleffs jc. AIDS. 1992 Feb;6(2):179-84. doi: 10.1097/00002030-199202000-00006. AIDS. 1992. PMID: 1348416

9

Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals.

Been-Tiktak AM, Williams I, Vrehen HM, Richens J, Aldam D, van Loon AM, Loveday C, Boucher CA, Ward P, Weller IV, Borleffs JC. Been-Tiktak AM, et al. Among authors: borleffs jc. Antimicrob Agents Chemother. 1996 Nov;40(11):2664-8. doi: 10.1128/AAC.40.11.2664. Antimicrob Agents Chemother. 1996. PMID: 8913487 Free PMC article. Clinical Trial.

10

Routine vaccination in HIV-infected patients: a review.

Borleffs JC, Schneider MM. Borleffs JC, et al. Neth J Med. 1994 Dec;45(6):244-9. Neth J Med. 1994. PMID: 7838239 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters